(Q36605428)

15 August 2017

1 reference

title

Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

15 August 2017

main subject

1 reference

1 reference

Eve J Lowenstein

1

1 reference

15 August 2017

language of work or name

1 reference

1 July 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

19

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

210-223

1 reference

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

What is polycystic ovary syndrome? Are national views important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

The genetics of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Hirsutism and acne in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

The evaluation and management of hirsutism*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

The effect of metformin on hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Correlation between endocrinological parameters and acne severity in adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Hyperandrogenemia in patients presenting with acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Prevalence of polycystic ovaries in women with androgenic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Protruding giant cervical polyp in a young adolescent with a previous rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

The role of androgens in determining acne severity in adult women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Update and future of hormonal therapy in acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

An observational study of Yasmin in the management of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Causes and management of hypertrichosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Biliopancreatic diversion as a novel approach to the HAIR-AN syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Should patients with polycystic ovarian syndrome be treated with metformin? A note of cautious optimism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Oral contraceptives and cyproterone acetate in female acne treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Excess Insulin Binding to Insulin-Like Growth Factor Receptors: Proposed Mechanism for Acanthosis Nigricans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Clinical profiles, occurrence, and management of adolescent patients with HAIR-AN syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Acanthosis nigricans associated with insulin resistance : pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Treatment of Acanthosis nigricans of the axillae using a long-pulsed (5-msec) alexandrite laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Clearance of acanthosis nigricans associated with the HAIR-AN syndrome after partial pancreatectomy: an 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

Hyperinsulinemic diseases of civilization: more than just Syndrome X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00077.X

10.1111/J.1529-8019.2006.00077.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference